Freeze and burn: new device targets lung cancer during bronchoscopy
NCT ID NCT07398027
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a device called the HybridTherm® system, which uses freezing and radiofrequency heat to destroy small lung tumors during a routine bronchoscopy. The procedure is done before the patient's planned surgery to remove the tumor. The main goals are to see if the device works as intended and to check for any serious bleeding. Only 20 people with early-stage lung cancer will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HybridTherm® System (device that combines freezing and radiofrequency heat to destroy tumors)
What this could lead to
If successful, this could provide a less invasive way to treat small lung tumors, potentially reducing the need for more extensive surgery.
What could go wrong
This is a very early, small study (20 people) focused on feasibility, not effectiveness. The procedure carries risks like bleeding, and it's unknown if it will work better than current treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Zurich
Zurich, Raemistrasse, 8091, Switzerland
Contact Email: •••••@•••••